CTIC

CTI BioPharma Corp. (DE) Common Stock
CTIC

Overview Fund Activity
Delisted

CTIC was delisted on the 23rd of June, 2023.

Back to rankings

56 hedge funds and large institutions have $160M invested in CTI BioPharma Corp. (DE) Common Stock in 2021 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 13 increasing their positions, 15 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
56
Holders Change
+6
Holders Change %
+12%
% of All Funds
0.98%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
13
Increased
13
Reduced
15
Closed
7
Calls
$287K
Puts
$431K
Net Calls
-$144K
Net Calls Change
-$647K

Top Buyers

1
SI
Sofinnova Investments
California
+$5.61M
2
KCM
Kennedy Capital Management
Missouri
+$1.49M
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$994K
4
SCM
Stonepine Capital Management
Oregon
+$979K
5
Verition Fund Management
Verition Fund Management
Connecticut
+$464K

Top Sellers

1
CC
Caxton Corporation
New Jersey
-$3.88M
2
Renaissance Technologies
Renaissance Technologies
New York
-$1.91M
3
Morgan Stanley
Morgan Stanley
New York
-$1.5M
4
ACM
Altium Capital Management
New York
-$1.08M
5
Two Sigma Investments
Two Sigma Investments
New York
-$598K
Name Holding Trade Value Shares
Change 		Shares
Change %
OSAM
51
O'Shaughnessy Asset Management
Connecticut
$1K -$265 -85 -21%
Squarepoint
52
Squarepoint
New York
– -$181K -72,325 Closed
OQS
53
Occudo Quantitative Strategies
Florida
– -$139K -55,555 Closed
Goldman Sachs
54
Goldman Sachs
New York
– -$104K -41,558 Closed
QSS
55
Quantitative Systematic Strategies
Florida
– -$64K -25,686 Closed
1 2
3